Dr Woodward's subspecialty interests are interventional and diagnostic (including abdominal CT, HPB and vascular CT/MRI) radiology.

GMC number


• EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. Gillmore R, Stuart S, Kirkwood A, Hameeduddin A, Woodward N, Burroughs AK, Meyer T. J Hepatol. 2011 Dec;55(6):1309-16. doi: 10.1016/j.jhep.2011.03.007. Epub 2011 Apr 15.
• Use of molecular imaging to differentiate liver metastasis of colorectal cancer metastasis from neuroendocrine tumor origin. Desai K, Watkins J, Woodward N, Quigley AM, Toumpanakis C, Bomanji J, Caplin M. J Clin Gastroenterol. 2011 Jan;45(1):e8-11
• Transarterial embolization/chemoebolization for hepatic NET metastases: recent efficacy and toxicity data. Walker RJ, Toumpanakis C, Marelli L, Yu D, Davies N, Woodward N, Goode A, Chilkunda D, Buscombe J, Meyer T, Caplin ME